Developing Oligonucleotides Into Therapies: Opportunities and Challenges

OTS-Event_9_

Categories: Past WebinarsPublished On: June 27th, 2023

Post Views: 1,893

Webinars

Sequence- and Structure-Dependent Cytotoxicity of Phosphorothioate and 2’-O-Methyl Modified Single-Stranded Oligonucleotides

OTS2024-08-30T15:58:39+00:00August 21st, 2024|

Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation

OTS2024-09-06T03:30:39+00:00July 25th, 2024|

A Nucleic Acid Approach to Antibody Therapeutics

OTS2024-09-06T03:30:14+00:00July 18th, 2024|

Application of hydrophobically conjugated siRNAs for the treatment of dermatological and muscular diseases

OTS2024-09-06T03:22:58+00:00July 11th, 2024|

SHARE

OTS-Event_9_

Time: 8AM PST / 11AM EST / 5PM CET
Date: July 6, 2023

Speakers:

Shalini

Shalini Andersson, PhD
Vice President of Oligonucleotide Discovery
AstraZeneca

Subscribe to our Newsletter

Oligonucleotide Therapeutics Society

Oligonucleotide Therapeutics Society

3960 W Point Loma Blvd, Suite H
Box 346
San Diego, CA 92110

info@oligotherapeutics.org

Terms & Conditions

Resources

Stay Connected

Search

Subscribe in a reader

© Copyright 2012 – 2024 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Enter Username or Email Address:
Password:
Forgot Password | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone:
Organization Name
Select Sectors

Already have an account? Login

This website uses cookies and third party services. Ok